SCLEROTHERAPY AS TREATMENT MODALITY FOR ORAL PYOGENIC GRANULOMA RANDOMIZED CONTROLLED CLINICAL TRIAL
edward, S., El Sayed, N., Darwish, Z., Anwar, S. (2022). SCLEROTHERAPY AS TREATMENT MODALITY FOR ORAL PYOGENIC GRANULOMA RANDOMIZED CONTROLLED CLINICAL TRIAL. EKB Journal Management System, 47(3), 49-53. doi: 10.21608/adjalexu.2022.111099.1239
sandra edward; Naguiba Mahmoud El Sayed; Zenab El sayed Darwish; Souzy Kamal Anwar. "SCLEROTHERAPY AS TREATMENT MODALITY FOR ORAL PYOGENIC GRANULOMA RANDOMIZED CONTROLLED CLINICAL TRIAL". EKB Journal Management System, 47, 3, 2022, 49-53. doi: 10.21608/adjalexu.2022.111099.1239
edward, S., El Sayed, N., Darwish, Z., Anwar, S. (2022). 'SCLEROTHERAPY AS TREATMENT MODALITY FOR ORAL PYOGENIC GRANULOMA RANDOMIZED CONTROLLED CLINICAL TRIAL', EKB Journal Management System, 47(3), pp. 49-53. doi: 10.21608/adjalexu.2022.111099.1239
edward, S., El Sayed, N., Darwish, Z., Anwar, S. SCLEROTHERAPY AS TREATMENT MODALITY FOR ORAL PYOGENIC GRANULOMA RANDOMIZED CONTROLLED CLINICAL TRIAL. EKB Journal Management System, 2022; 47(3): 49-53. doi: 10.21608/adjalexu.2022.111099.1239